Please assess the completion status of the following clinical trial:

Trial Title: Post-Stroke Aphasia and Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18 years~* LMCA stroke as indicated by the presence of aphasia and MRI lesion in the LMCA distribution~* Moderate aphasia (Token Test score between 40th and 90th percentile)~* Fluency in English~* Provision of written informed consent by the patient and/or the next of kin~Exclusion Criteria:~* Age less than 18 years~* Underlying degenerative or metabolic disorder or supervening medical illness~* Severe depression or other psychiatric disorder~* Positive pregnancy test in women of childbearing age~* Any contraindication to MRI/fMRI at 3T (i.e., intracranial metal implants, claustrophobia)~* Any contraindication to nerTMS (e.g., seizures or epilepsy)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- rTMS (Type: EXPERIMENTAL): 3 weeks of nerTMS
- 1 week of Sham Treatment + 2 weeks of nerTMS (Type: SHAM_COMPARATOR): 1 week of Sham Treatment + 2 weeks of nerTMS
- 2 weeks of Sham Treatment +1 week of nerTMS (Type: SHAM_COMPARATOR): 2 weeks of Sham Treatment +1 week of nerTMS
- Control Group (Type: PLACEBO_COMPARATOR): 3 weeks of Sham Treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).